Stringency in Polycystic Ovary Syndrome (PCOS) Criteria and Application in Clinical Study

  • Catherine Ward University of California, Berkeley, USA
  • Heather Huddleston University of California, Berkeley, USA
  • Umesh Masharani University of California, Berkeley
  • Umesh Masharani University of California, Berkeley
  • Ashley E. Mason University of California San Francisco, USA
  • Lynda Frassetto University of California San Francisco, USA
Keywords: Insulin resistance, Obesity, Clinical trial, Diet, Menstrual cycle, Hyperandrogenism, Polycystic ovary syndrome

Abstract

In this manuscript, we review the various criteria used to diagnose PCOS and discuss how the specific diagnostic criteria used can impact recruitment for PCOS studies. PCOS is a common diagnosis but with several differing definitions. We were interested in addressing these differing stringencies and application in a clinical trial, such as our group’s PCOS diet study. For our study on the effects of diets to alter insulin resistance, we adopted the one using more stringent criteria, consisting of biochemical abnormalities, menstrual abnormalities, insulin resistance, and abnormal ovarian size and structure. Our study actively recruits from PCOS clinics in the Bay Area. We reported some women successfully recruited using our PCOS diagnosis stringency, and how these numbers differ from women referred to PCOS clinics in the Bay Area. We also report the reasons patients did not fit our diagnosis criteria to shed insight into how diagnoses differ between healthcare professionals. To our surprise, the vast majority of subjects seen in the tertiary referral PCOS center at UCSF did not qualify for the study. The definition of PCOS may be important in study design and can impact the ability to recruit for the study. Date of registration: June 20, 2014, NIH ClinicalTrials.gov identifier: NCT02190097.

Downloads

Download data is not yet available.

References

Azziz, R, Woods, K, Reyna, R, Key, T, Knochenhauer, E and Yildiz, B. (2004). The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population. The Journal of Clinical Endocrinology & Metabolism, 89(6), pp.2745-2749.

Yildiz, B, Bozdag, G, Yapici, Z, Esinler, I and Yarali, H. (2012). Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Human Reproduction, 27(10), pp.3067-3073.

March, W, Moore, V, Willson, K, Phillips, D, Norman, R and Davies, M. (2009). The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction, 25(2), pp.544-551.

Lizneva, D, Kirubakaran, R, Mykhalchenko, K, et al. (2016). Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Fertility and Sterility, 106(6), pp.1510-1520.e2.

Fauser, B, Tarlatzis, B, Rebar, R, et al. (2012). Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility, 97(1), pp.28-38.e25.

Franks, S, Stark, J and Hardy, K. (2008). Follicle dynamics and anovulation in polycystic ovary syndrome. Human Reproduction Update, 14(4), pp.367-378.

Goodman, N, Cobin, R, Futterweit, W, Glueck, J, Legro, R and Carmina, E. (2015). AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 1. Endocrine Practice, 21(11), pp.1291-1300.

Silfen, M, Denburg, M, Manibo, A, et al. (2003). Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents. The Journal of Clinical Endocrinology & Metabolism, 88(10), pp.4682-4688.

Fontes-Villalba, M, Jönsson, T, Granfeldt, Y, et al. (2014). A healthy diet with and without cereal grains and dairy products in patients with type 2 diabetes: study protocol for a random-order cross-over pilot study - Alimentation and Diabetes in Lanzarote -ADILAN. Trials, 15(1).

Masharani, U, Sherchan, P, Schloetter, M, et al. (2015). Metabolic and physiologic effects from consuming a hunter-gatherer (Paleolithic)-type diet in type 2 diabetes. European Journal of Clinical Nutrition, 69(8), pp.944-948.

Feinman, R, Pogozelski, W, Astrup, A, et al. (2015). Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base. Nutrition, 31(1), pp.1-13.

Frassetto, L, Shi, L, Schloetter, M, Sebastian, A and Remer, T. (2013). Established dietary estimates of net acid production do not predict measured net acid excretion in patients with Type 2 diabetes on Paleolithic–Hunter–Gatherer-type diets. European Journal of Clinical Nutrition, 67(9), pp.899-903.

Stein, I and Leventhal, M. (1935). Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology, 29(2), pp.181-191.

Wang, R and Mol, B. (2016). The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?. Human Reproduction, 32(2), pp.261-264.

The Rotterdam ESHRE/ASRM‐sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). (2004). Human Reproduction, 19(1), pp.41-47.

Azziz, R, Carmina, E, Dewailly, D, et al. (2009). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility, 91(2), pp.456-488.

Azziz, R, Carmina, E, Dewailly, D, et al. (2006). Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism, 91(11), pp.4237-4245.

Iliodromiti, S, Kelsey, T, Anderson, R and Nelson, S. (2013). Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data. The Journal of Clinical Endocrinology & Metabolism, 98(8), pp.3332-3340.

Tal, R, Tal, O, Seifer, B and Seifer, D. (2015). Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertility and Sterility, 103(1), pp.119-130.e3.

Lizneva, D, Kirubakaran, R, Mykhalchenko, K, et al. (2016). Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Fertility and Sterility, 106(6), pp.1510-1520.e2.

Zawadski J and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, ed. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications. 1992. 377–384.

Lizneva, D, Kirubakaran, R, Mykhalchenko, K, et al. (2016). Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Fertility and Sterility, 106(6), pp.1510-1520.e2.

Dunaif, A. (1995). Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. The American Journal of Medicine, 98(1), pp.S33-S39.

Dunaif, A, Wu, X, Lee, A. and Diamanti-Kandarakis, E. (2001). Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). American Journal of Physiology-Endocrinology and Metabolism, 281(2), pp.E392-E399.

Cassar, S, Misso, M, Hopkins, W, Shaw, C, Teede, H and Stepto, N. (2016). Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies. Human Reproduction, 31(11), pp.2619-2631.

Lashen H. Role of metformin in the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2010;1(3):117-128.

Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, et al. (2016). Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecological Endocrinology, 32(5), pp.343-53.

Gambineri, A, Pelusi, C, Vicennati, V, Pagotto, U and Pasquali, R. (2002). Obesity and the polycystic ovary syndrome. International Journal of Obesity, 26(7), pp.883-896.

Carmina, E and Lobo, R. (1999). Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women. Journal of Clinical Endocrinology & Metabolism, 84(6), pp.1897-1899.

Published
2022-02-09
How to Cite
Ward, C., Huddleston, H., Masharani, U., Masharani, U., Mason, A., & Frassetto, L. (2022). Stringency in Polycystic Ovary Syndrome (PCOS) Criteria and Application in Clinical Study. Journal of Infertility and Reproductive Biology, 10(1), 7-9. https://doi.org/10.47277/JIRB/10(1)/7
Section
Regular publication process (free of charge)